Join industry leaders as they explore crucial trends and shifts in market access, economic conditions, and regulatory landscapes affecting the biotech and pharma sectors. This panel will provide insights into adapting business strategies in a rapidly changing environment and offer strategic advice for the coming year.
- Regulatory Changes and Pricing Impacts: A healthcare policy expert will discuss recent regulatory changes, including those stemming from new legislation such as the IRA, focusing on their impact on drug pricing and market access strategies.
- Market Access Challenges: An executive from a leading pharma company will address ongoing challenges in market access, detailing the evolving payer expectations and the importance of strategic pricing models to enhance patient access and affordability.
- Economic and Market Trends: An industry analyst will provide an overview of current economic trends, investment patterns, and market conditions that are shaping the biotech and pharma industries, highlighting how companies can leverage these trends for growth.
- Strategic Advice for the Next 12 Months: A seasoned pharma executive will offer practical advice on navigating the industry's complexities over the next year, emphasizing flexibility in operations, innovation in product pipelines, and effective stakeholder engagement.
This panel aims to give attendees a comprehensive view of the key factors driving changes in the biotech and pharma sectors, equipping them with the knowledge to make informed decisions and strategically position their companies for success.
